Approval · Notice of Compliance 3476 · 2003
ACTOS: Notice of Compliance 3476
Issued February 13, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3476
- Date
- February 13, 2003
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: combination therapy (with a sulfonylurea or metformin) in patients with type 2 diabetes
- Therapeutic class
- Anti-diabetic agent, insulin resistance reducing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTOS | Not yet assigned | — |
Medicinal ingredients
- PIOGLITAZONE HYDROCHLORIDE 15 MG per TAB
- PIOGLITAZONE HYDROCHLORIDE 30 MG per TAB
- PIOGLITAZONE HYDROCHLORIDE 45 MG per TAB